{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:47:01Z","timestamp":1792183621109,"version":"4.4.0"},"reference-count":85,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2013,2,28]],"date-time":"2013-02-28T00:00:00Z","timestamp":1362009600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1003173","type":"journal-article","created":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T13:33:07Z","timestamp":1362144787000},"page":"e1003173","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":47,"title":["Viral Escape from Neutralizing Antibodies in Early Subtype A HIV-1 Infection Drives an Increase in Autologous Neutralization Breadth"],"prefix":"10.1371","volume":"9","author":[{"given":"Megan K.","family":"Murphy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruimin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saikat","family":"Boliar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anurag","family":"Sethi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhui","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Pfafferot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Karita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan A.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Cormier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Goepfert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Persephone","family":"Borrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Gnanakaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Peng","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia A.","family":"Derdeyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,2,28]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","volume":"17","author":"SA Plotkin","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1056\/NEJMoa1113425","article-title":"Immune-correlates analysis of an HIV-1 vaccine efficacy trial","volume":"366","author":"BF Haynes","year":"2012","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nature10766","article-title":"Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys","volume":"482","author":"DH Barouch","year":"2012","journal-title":"Nature"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1098\/rstb.2011.0096","article-title":"Progress in the rational design of an AIDS vaccine","volume":"366","author":"GJ Nabel","year":"2011","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1128\/JVI.06973-11","article-title":"PGV04, an HIV-1 gp120 CD4 Binding Site Antibody, Is Broad and Potent in Neutralization but Does Not Induce Conformational Changes Characteristic of CD4","volume":"86","author":"E Falkowska","year":"2012","journal-title":"J Virol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nature10373","article-title":"Broad neutralization coverage of HIV by multiple highly potent antibodies","volume":"477","author":"LM Walker","year":"2011","journal-title":"Nature"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1126\/science.1192819","article-title":"Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01","volume":"329","author":"T Zhou","year":"2010","journal-title":"Science"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1126\/science.1213256","article-title":"A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield","volume":"334","author":"R Pejchal","year":"2011","journal-title":"Science"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"10892","DOI":"10.1128\/JVI.75.22.10892-10905.2001","article-title":"Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41","volume":"75","author":"MB Zwick","year":"2001","journal-title":"J Virol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"e23532","DOI":"10.1371\/journal.pone.0023532","article-title":"Isolation of a human anti-HIV gp41 membrane proximal region neutralizing antibody by antigen-specific single B cell sorting","volume":"6","author":"L Morris","year":"2011","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nature11544","article-title":"Broad and potent neutralization of HIV-1 by a gp41-specific human antibody","volume":"491","author":"J Huang","year":"2012","journal-title":"Nature"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nature10696","article-title":"Structure of HIV-1 gp120 V1\/V2 domain with broadly neutralizing antibody PG9","volume":"480","author":"JS McLellan","year":"2011","journal-title":"Nature"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1126\/science.1207532","article-title":"Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing","volume":"333","author":"X Wu","year":"2011","journal-title":"Science"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"9057","DOI":"10.1073\/pnas.0901474106","article-title":"Broadly neutralizing anti-HIV-1 antibodies disrupt a hinge-related function of gp41 at the membrane interface","volume":"106","author":"L Song","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1126\/science.1207227","article-title":"Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding","volume":"333","author":"JF Scheid","year":"2011","journal-title":"Science"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e1001251","DOI":"10.1371\/journal.ppat.1001251","article-title":"Characteristics of the earliest cross-neutralizing antibody response to HIV-1","volume":"7","author":"I Mikell","year":"2011","journal-title":"PLoS Pathog"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.1128\/JVI.00198-11","article-title":"The neutralization breadth of HIV-1 develops incrementally over four years and is associated with CD4+ T cell decline and high viral load during acute infection","volume":"85","author":"ES Gray","year":"2011","journal-title":"J Virol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"7337","DOI":"10.1128\/JVI.00110-09","article-title":"Human immunodeficiency virus type 1 elite neutralizers: individuals with broad and potent neutralizing activity identified by using a high-throughput neutralization assay together with an analytical selection algorithm","volume":"83","author":"MD Simek","year":"2009","journal-title":"J Virol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1073\/pnas.0912914107","article-title":"Autoreactivity in an HIV-1 broadly reactive neutralizing antibody variable region heavy chain induces immunologic tolerance","volume":"107","author":"L Verkoczy","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1128\/JVI.02036-08","article-title":"Factors associated with the development of cross-reactive neutralizing antibodies during human immunodeficiency virus type 1 infection","volume":"83","author":"DN Sather","year":"2009","journal-title":"J Virol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"e25606","DOI":"10.1371\/journal.pone.0025606","article-title":"Antibody V(h) repertoire differences between resolving and chronically evolving hepatitis C virus infections","volume":"6","author":"V Racanelli","year":"2011","journal-title":"PLoS One"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1073\/pnas.0308527100","article-title":"Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120","volume":"101","author":"CC Huang","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref23","unstructured":"Moore PL, Gray ES, Hermanus T, Sheward D, Tumba N, <etal>et al<\/etal>.. (2011) Evolution of HIV-1 Transmitted\/Founder Viruses Results in the Formation of Epitopes for Later Broadly Cross-Neutralizing Antibodies. In: Retroviruses ARaH, editor. AIDS Vaccine 2011. Bangkok, Thailand: Mary Ann Liebert, Inc."},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1038\/nm.2985","article-title":"Evolution of an HIV glycan-dependent broadly neutralizing antibody epitope through immune escape","volume":"18","author":"PL Moore","year":"2012","journal-title":"Nat Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"e1002721","DOI":"10.1371\/journal.ppat.1002721","article-title":"Early Low-Titer Neutralizing Antibodies Impede HIV-1 Replication and Select for Virus Escape","volume":"8","author":"KJ Bar","year":"2012","journal-title":"PLoS Pathog"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.1073\/pnas.0630530100","article-title":"Rapid evolution of the neutralizing antibody response to HIV type 1 infection","volume":"100","author":"DD Richman","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nature01470","article-title":"Antibody Neutralization and Escape by HIV-1","volume":"422","author":"X Wei","year":"2003","journal-title":"Nature"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"e1000598","DOI":"10.1371\/journal.ppat.1000598","article-title":"Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection","volume":"5","author":"PL Moore","year":"2009","journal-title":"PLoS Pathog"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"e1000594","DOI":"10.1371\/journal.ppat.1000594","article-title":"Escape from autologous neutralizing antibodies in acute\/early subtype C HIV-1 infection requires multiple pathways","volume":"5","author":"R Rong","year":"2009","journal-title":"PLoS Pathog"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.virol.2009.11.032","article-title":"Temporal analysis of HIV envelope sequence evolution and antibody escape in a subtype A-infected individual with a broad neutralizing antibody response","volume":"398","author":"KA Bosch","year":"2009","journal-title":"Virology"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1128\/JVI.02006-10","article-title":"The B cell response is redundant and highly focused on V1V2 during early subtype C infection in a Zambian seroconverter","volume":"85","author":"RM Lynch","year":"2011","journal-title":"J Virol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1093\/bioinformatics\/btk004","article-title":"SoDA: implementation of a 3D alignment algorithm for inference of antigen receptor recombinations","volume":"22","author":"JM Volpe","year":"2006","journal-title":"Bioinformatics"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.4049\/jimmunol.147.5.1709","article-title":"Identical V region amino acid sequences and segments of sequences in antibodies of different specificities. Relative contributions of VH and VL genes, minigenes, and complementarity-determining regions to binding of antibody-combining sites","volume":"147","author":"EA Kabat","year":"1991","journal-title":"J Immunol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"7293","DOI":"10.1128\/JVI.76.14.7293-7305.2002","article-title":"The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120","volume":"76","author":"RW Sanders","year":"2002","journal-title":"J Virol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"7306","DOI":"10.1128\/JVI.76.14.7306-7321.2002","article-title":"The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1\u21922 mannose residues on the outer face of gp120","volume":"76","author":"CN Scanlan","year":"2002","journal-title":"J Virol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1128\/JVI.02187-07","article-title":"The C3-V4 Region Is a Major Target of Autologous Neutralizing Antibodies in Hiv-1 Subtype C Infection","volume":"82","author":"PL Moore","year":"2007","journal-title":"J Virol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.1128\/JVI.00201-06","article-title":"Evidence for potent autologous neutralizing antibody titers and compact envelopes in early infection with subtype C human immunodeficiency virus type 1","volume":"80","author":"B Li","year":"2006","journal-title":"J Virol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"9286","DOI":"10.1128\/JVI.02286-10","article-title":"Epitopes immediately below the base of the V3 loop of gp120 as targets for the initial autologous neutralizing antibody response in two HIV-1 subtype B-infected individuals","volume":"85","author":"H Tang","year":"2011","journal-title":"J Virol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"11401","DOI":"10.1128\/JVI.05312-11","article-title":"Cross-reactive HIV-1-neutralizing human monoclonal antibodies identified from a patient with 2F5-like antibodies","volume":"85","author":"Z Zhu","year":"2011","journal-title":"J Virol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"9998","DOI":"10.1128\/JVI.05045-11","article-title":"Analysis of a clonal lineage of HIV-1 envelope V2\/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors","volume":"85","author":"M Bonsignori","year":"2011","journal-title":"J Virol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"e27780","DOI":"10.1371\/journal.pone.0027780","article-title":"Human Anti-V3 HIV-1 Monoclonal Antibodies Encoded by the VH5-51\/VL Lambda Genes Define a Conserved Antigenic Structure","volume":"6","author":"MK Gorny","year":"2011","journal-title":"PLoS One"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.molimm.2008.09.005","article-title":"Preferential use of the VH5-51 gene segment by the human immune response to code for antibodies against the V3 domain of HIV-1","volume":"46","author":"MK Gorny","year":"2009","journal-title":"Mol Immunol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1126\/science.1213782","article-title":"Increasing the potency and breadth of an HIV antibody by using structure-based rational design","volume":"334","author":"R Diskin","year":"2011","journal-title":"Science"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1128\/JVI.02335-10","article-title":"Crystal structure of human antibody 2909 reveals conserved features of quaternary structure-specific antibodies that potently neutralize HIV-1","volume":"85","author":"A Changela","year":"2011","journal-title":"J Virol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1086\/514243","article-title":"Mother-child class I HLA concordance increases perinatal human immunodeficiency virus type 1 transmission","volume":"177","author":"KS MacDonald","year":"1998","journal-title":"J Infect Dis"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"5262","DOI":"10.1128\/JVI.02419-10","article-title":"Sequential immunization with a subtype B HIV-1 envelope quasispecies partially mimics the in vivo development of neutralizing antibodies","volume":"85","author":"DC Malherbe","year":"2011","journal-title":"J Virol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"e1000274","DOI":"10.1371\/journal.ppat.1000274","article-title":"Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1","volume":"5","author":"RE Haaland","year":"2009","journal-title":"PLoS Pathog"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1089\/aid.2010.0030","article-title":"Transmitted HIV type 1 drug resistance among individuals with recent HIV infection in East and Southern Africa","volume":"27","author":"MA Price","year":"2011","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1128\/JVI.02660-07","article-title":"Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing","volume":"82","author":"JF Salazar-Gonzalez","year":"2008","journal-title":"J Virol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/QAD.0b013e32805e8727","article-title":"HIV-1 subtype A envelope variants from early in infection have variable sensitivity to neutralization and to inhibitors of viral entry","volume":"21","author":"CA Blish","year":"2007","journal-title":"Aids"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/088922202753747914","article-title":"HIV type 1 variants transmitted to women in Kenya require the CCR5 coreceptor for entry, regardless of the genetic complexity of the infecting virus","volume":"18","author":"EM Long","year":"2002","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"5255","DOI":"10.1128\/JVI.73.7.5255-5264.1999","article-title":"Variants from the diverse virus population identified at seroconversion of a clade A human immunodeficiency virus type 1-infected woman have distinct biological properties","volume":"73","author":"M Poss","year":"1999","journal-title":"J Virol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"10108","DOI":"10.1128\/JVI.79.16.10108-10125.2005","article-title":"Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies","volume":"79","author":"M Li","year":"2005","journal-title":"J Virol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.virol.2006.10.017","article-title":"Antigenicity and immunogenicity of HIV-1 consensus subtype B envelope glycoproteins","volume":"360","author":"DL Kothe","year":"2007","journal-title":"Virology"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.virol.2006.05.011","article-title":"Ancestral and consensus envelope immunogens for HIV-1 subtype C","volume":"352","author":"DL Kothe","year":"2006","journal-title":"Virology"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"11776","DOI":"10.1128\/JVI.01730-06","article-title":"Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa","volume":"80","author":"M Li","year":"2006","journal-title":"J Virol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1126\/science.1093137","article-title":"Envelope-Constrained Neutralization-Sensitive HIV-1 After Heterosexual Transmission","volume":"303","author":"CA Derdeyn","year":"2004","journal-title":"Science"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1128\/JVI.01839-06","article-title":"Role of V1V2 and other human immunodeficiency virus type 1 envelope domains in resistance to autologous neutralization during clade C infection","volume":"81","author":"R Rong","year":"2007","journal-title":"J Virol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.virol.2010.04.010","article-title":"Subtype-specific conservation of isoleucine 309 in the envelope V3 domain is linked to immune evasion in subtype C HIV-1 infection","volume":"404","author":"RM Lynch","year":"2010","journal-title":"Virology"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1128\/JVI.00257-07","article-title":"Unique Mutational Patterns in the Envelope {alpha}2 Amphipathic Helix and Acquisition of Length in gp120 Hyper-variable Domains are Associated with Resistance to Autologous Neutralization of Subtype C Human Immunodeficiency Virus type 1","volume":"81","author":"R Rong","year":"2007","journal-title":"J Virol"},{"key":"ref61","first-page":"Unit 5 6","article-title":"Comparative protein structure modeling using Modeller","volume":"5","author":"N Eswar","year":"2006","journal-title":"Curr Protoc Bioinformatics Chapter"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1002\/jcc.20289","article-title":"Scalable molecular dynamics with NAMD","volume":"26","author":"JC Phillips","year":"2005","journal-title":"J Comput Chem"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0969-2126(00)00547-5","article-title":"Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates","volume":"8","author":"PD Kwong","year":"2000","journal-title":"Structure Fold Des"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1126\/science.1118398","article-title":"Structure of a V3-containing HIV-1 gp120 core","volume":"310","author":"CC Huang","year":"2005","journal-title":"Science"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/nature05580","article-title":"Structural definition of a conserved neutralization epitope on HIV-1 gp120","volume":"445","author":"T Zhou","year":"2007","journal-title":"Nature"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1073\/pnas.0911004107","article-title":"Structure of HIV-1 gp120 with gp41-interactive region reveals layered envelope architecture and basis of conformational mobility","volume":"107","author":"M Pancera","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nature07159","article-title":"Molecular architecture of native HIV-1 gp120 trimers","volume":"455","author":"J Liu","year":"2008","journal-title":"Nature"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"13800","DOI":"10.1073\/pnas.1006498107","article-title":"Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens","volume":"107","author":"KJ Doores","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/prot.21123","article-title":"Comparison of multiple Amber force fields and development of improved protein backbone parameters","volume":"65","author":"V Hornak","year":"2006","journal-title":"Proteins"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/jcc.20820","article-title":"GLYCAM06: a generalizable biomolecular force field. Carbohydrates","volume":"29","author":"KN Kirschner","year":"2008","journal-title":"J Comput Chem"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0021-9673(01)87461-6","article-title":"Characterization of recombinant human interleukin-2 with micromethods","volume":"326","author":"HW Lahm","year":"1985","journal-title":"J Chromatogr"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jviromet.2009.02.014","article-title":"High-throughput isolation of immunoglobulin genes from single human B cells and expression as monoclonal antibodies","volume":"158","author":"HX Liao","year":"2009","journal-title":"J Virol Methods"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.pep.2005.09.022","article-title":"An improved method for fast, robust, and seamless integration of DNA fragments into multiple plasmids","volume":"45","author":"RM Benoit","year":"2006","journal-title":"Protein Expr Purif"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jim.2007.09.017","article-title":"Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning","volume":"329","author":"T Tiller","year":"2008","journal-title":"J Immunol Methods"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nprot.2009.3","article-title":"Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen","volume":"4","author":"K Smith","year":"2009","journal-title":"Nat Protoc"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1126\/science.1178746","article-title":"Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target","volume":"326","author":"LM Walker","year":"2009","journal-title":"Science"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/nsmb.1861","article-title":"Conserved structural elements in the V3 crown of HIV-1 gp120","volume":"17","author":"X Jiang","year":"2010","journal-title":"Nat Struct Mol Biol"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.str.2011.02.012","article-title":"Structural analysis of human and macaque mAbs 2909 and 2.5B: implications for the configuration of the quaternary neutralizing epitope of HIV-1 gp120","volume":"19","author":"B Spurrier","year":"2011","journal-title":"Structure"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.str.2009.09.012","article-title":"Structural basis of the cross-reactivity of genetically related human anti-HIV-1 mAbs: implications for design of V3-based immunogens","volume":"17","author":"V Burke","year":"2009","journal-title":"Structure"},{"key":"ref80","doi-asserted-by":"crossref","unstructured":"Otwinowski Z, Minor W (1997) Processing of X-Ray Diffraction Data Collected in Oscillation Mode. In: Carter CW, editor. Methods in Enzymology. Salt Lake City, UT: Academic Press, Inc. pp. 307\u2013326.","DOI":"10.1016\/S0076-6879(97)76066-X"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1107\/S0907444909042589","article-title":"Molecular replacement with MOLREP","volume":"66","author":"A Vagin","year":"2010","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1107\/S0907444910045749","article-title":"Overview of the CCP4 suite and current developments","volume":"67","author":"MD Winn","year":"2011","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: model-building tools for molecular graphics","volume":"60","author":"P Emsley","year":"2004","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1107\/S0907444902016657","article-title":"PHENIX: building new software for automated crystallographic structure determination","volume":"58","author":"PD Adams","year":"2002","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/jcc.540150503","article-title":"ICM\u2014A new method for protein modeling and design: Applications to docking and structure prediction from the distorted native conformation","volume":"15","author":"R Abagyan","year":"1994","journal-title":"J Comput Chem"}],"container-title":["PLoS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1003173","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T17:39:04Z","timestamp":1715017144000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1003173"}},"subtitle":[],"editor":[{"given":"Alexandra","family":"Trkola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,2,28]]},"references-count":85,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2013,2,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1003173","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,28]]}}}